For research use only. Not for therapeutic Use.
Anselamimab (CAEL-101) a humanized IgG1-κ anti-Amyloid fibrils antibody targeting to serum amyloid A1 (SAA1)[1][2].
| Catalog Number | I040856 |
| CAS Number | 2414866-63-8 |
| Purity | ≥95% |
| Reference | [1]. Palladini G, et al. How I treat AL amyloidosis. Blood. 2022 May 12;139(19):2918-2930. [2]. Anselamimab. IMGT/mAb-DB. |
